UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000026255
Receipt No. R000030082
Official scientific title of the study A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery
Date of disclosure of the study information 2017/02/22
Last modified on 2019/02/25 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery
Title of the study (Brief title) A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery
Region
Japan

Condition
Condition lumbar spinal canal stenosis
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the reducing effect of postopertive epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendoscopic surgery
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes quantity of postoperative drainage at 36 hours after surgery
Key secondary outcomes numerical rating scale(NRS) of postoperative leg pain
size of area of haematoma on the axial image of MRI examined a few days after surgery

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 When decompression procedure is finished and operation of hemostasis is completed in microendoscopic spinal surgery, surgeon is told whether the patient belongs to a group of FloSeal or control. If a FloSeal group, FloSeal (5ml) is applied to around dura. After then, drainage is put in surgical field and surgical procedure is finished.
Interventions/Control_2 When decompression procedure is finished and operation of hemostasis is completed in microendoscopic spinal surgery, surgeon is told whether the patient belongs to a group of FloSeal or control. If a control group, drainage is put in surgical field and surgical procedure is finished.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with lumbar spinal canal stenosis who undergo microendoscopic spinal surgery in our hospital
Key exclusion criteria Patients who have hemorrahagic factors (hemodialysis, liver cirrhosis, etc)
Patients of foraminal stenosis
Patients of re-operation
Patients who suffer dural tear intraoperatively
Patients whose drainage is put unsuitably
Patients who are thought that use of FloSeal is mandatory because of difficulty of hemostasis in the surgical field
Others who are inadequate to current study
Target sample size 60

Research contact person
Name of lead principal investigator Masanari Takami
Organization Wakayama Medical University
Division name Department of orthopaedic surgery
Address 811-1 Kimiidra, Wakayama, Japan
TEL 073-441-0645
Email maatomo324@gmail.com

Public contact
Name of contact person Masanari Takami
Organization Wakayama Medical University
Division name Department of orthopaedic surgery
Address 811-1 Kimiidra, Wakayama, Japan
TEL 073-441-0645
Homepage URL
Email maatomo324@gmail.com

Sponsor
Institute Department of orthopaedic surgery, Wakayama Medical University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 22 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 02 Month 22 Day
Anticipated trial start date
2017 Year 02 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 02 Month 21 Day
Last modified on
2019 Year 02 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030082